Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-25 @ 4:26 AM
NCT ID:
NCT01795820
Eligibility Criteria:
Inclusion Criteria:
* Acute Coronary Syndrome
* Current dual anti platelet treatment with ASA and Clopidogrel
Exclusion Criteria:
* No coronary revascularization within the previous six months
* Ongoing therapy with ticagrelor, prasugrel or ticlopidine before enrollment
* No treatment with glycoprotein IIb/IIIa inhibitors within the previous 6 days
* Patients which are known to be no responders to Clopidogrel
* Known neoplastic or autoimmune disease
* Liver cirrhosis
* Severe pulmonary disease
* Known disorder of Haemostasis
* Previous Stroke
* Ongoing pregnancy
* Therapy with any inhibitor of P450 Cytochrome until 15 days before enrollment
* Low platelet count or Hb\<10 g/dl
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01795820
Study Brief:
Protocol Section:
NCT01795820